Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L W Fitzgerald

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Journal of Neurochemistry|April 1, 1994
Chronic ingestion of ethanol up-regulates NMDAR1 receptor subunit immunoreactivity in rat hippocampusL Trevisan, L W Fitzgerald, N Brose, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 1999
Thiazolo[4,5-d]pyrimidine thiones and -ones as corticotropin-releasing hormone (CRH-R1) receptor antagonistsJ P Beck, M A Curry, R J Chorvat, et al.
Synapse (New York, N.Y.)|December 1, 1995
Biochemical actions of chronic ethanol exposure in the mesolimbic dopamine systemJ Ortiz, L W Fitzgerald, M Charlton, et al.
Bioorganic & Medicinal Chemistry Letters|May 7, 1999
Purin-8-ones as corticotropin-releasing hormone (CRH-R1) receptor antagonistsJ P Beck, A G Arvanitis, M A Curry, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 5, 1999
Messenger RNA editing of the human serotonin 5-HT2C receptorL W Fitzgerald, G Iyer, D S Conklin, et al.
Journal of Neurochemistry|April 27, 1999
High-affinity agonist binding correlates with efficacy (intrinsic activity) at the human serotonin 5-HT2A and 5-HT2C receptors: evidence favoring the ternary complex and two-state models of agonist actionL W Fitzgerald, D S Conklin, C M Krause, et al.
Journal of Medicinal Chemistry|February 12, 2000
4-(1,3-Dimethoxyprop-2-ylamino)-2,7-dimethyl-8-(2, 4-dichlorophenyl)pyrazolo[1,5-a]-1,3,5-triazine: a potent, orally bioavailable CRF(1) receptor antagonistL He, P J Gilligan, R Zaczek, et al.
Bioorganic & Medicinal Chemistry|September 1, 2000
The discovery of 4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1 ,5-a]-pyrimidine: a corticotropin-releasing factor (hCRF1) antagonistP J Gilligan, C Baldauf, A Cocuzza, et al.
Molecular Pharmacology|January 5, 2000
Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramineL W Fitzgerald, T C Burn, B S Brown, et al.
Journal of Medicinal Chemistry|March 12, 1999
Synthesis, corticotropin-releasing factor receptor binding affinity, and pharmacokinetic properties of triazolo-, imidazo-, and pyrrolopyrimidines and -pyridinesR J Chorvat, R Bakthavatchalam, J P Beck, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Neurochemistry|April 1, 1994
Chronic ingestion of ethanol up-regulates NMDAR1 receptor subunit immunoreactivity in rat hippocampusL Trevisan, L W Fitzgerald, N Brose, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 1999
Thiazolo[4,5-d]pyrimidine thiones and -ones as corticotropin-releasing hormone (CRH-R1) receptor antagonistsJ P Beck, M A Curry, R J Chorvat, et al.
Synapse (New York, N.Y.)|December 1, 1995
Biochemical actions of chronic ethanol exposure in the mesolimbic dopamine systemJ Ortiz, L W Fitzgerald, M Charlton, et al.
Bioorganic & Medicinal Chemistry Letters|May 7, 1999
Purin-8-ones as corticotropin-releasing hormone (CRH-R1) receptor antagonistsJ P Beck, A G Arvanitis, M A Curry, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 5, 1999
Messenger RNA editing of the human serotonin 5-HT2C receptorL W Fitzgerald, G Iyer, D S Conklin, et al.
Journal of Neurochemistry|April 27, 1999
High-affinity agonist binding correlates with efficacy (intrinsic activity) at the human serotonin 5-HT2A and 5-HT2C receptors: evidence favoring the ternary complex and two-state models of agonist actionL W Fitzgerald, D S Conklin, C M Krause, et al.
Journal of Medicinal Chemistry|February 12, 2000
4-(1,3-Dimethoxyprop-2-ylamino)-2,7-dimethyl-8-(2, 4-dichlorophenyl)pyrazolo[1,5-a]-1,3,5-triazine: a potent, orally bioavailable CRF(1) receptor antagonistL He, P J Gilligan, R Zaczek, et al.
Bioorganic & Medicinal Chemistry|September 1, 2000
The discovery of 4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1 ,5-a]-pyrimidine: a corticotropin-releasing factor (hCRF1) antagonistP J Gilligan, C Baldauf, A Cocuzza, et al.
Molecular Pharmacology|January 5, 2000
Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramineL W Fitzgerald, T C Burn, B S Brown, et al.
Journal of Medicinal Chemistry|March 12, 1999
Synthesis, corticotropin-releasing factor receptor binding affinity, and pharmacokinetic properties of triazolo-, imidazo-, and pyrrolopyrimidines and -pyridinesR J Chorvat, R Bakthavatchalam, J P Beck, et al.
Pageof 3